MedElevator Войти в исследования
← Поиск публикаций

DOI 10.5114/kitp.2018.74668

Медицинская библиотека · Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery · 2018

Ropivacaine has no advantage over bupivacaine in thoracic epidural analgesia for patients with pectus excavatum undergoing the Nuss procedure - a single blind randomized clinical trial comparing efficacy and safety.

Walaszczyk Małgorzata, Wiench Rafał, Copik Maja, Karpe Jacek, Łowicka Małgorzata, Pióro Anna, Knapik Piotr, Misiołek Hanna

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Pectus excavatum repair (Nuss procedure) is a painful procedure requiring effective postoperative analgesia.

AIM: To establish whether thoracic epidural analgesia with ropivacaine is non-inferior to epidural analgesia with bupivacaine following the Nuss procedure in children.

MATERIAL AND

METHODS

The prospective, randomized, controlled, single blind study included 81 children. Computer-generated random numbers were used to allocate treatment. All children received general anesthesia. Intraoperative and postoperative analgesia was achieved with either 0.5% and 0.1% ropivacaine (group R) or 0.375% and 0.0625% bupivacaine (group B). The Numeric Rating Scale (NRS) and the Prince Henry Hospital Pain Score (PHHPS) were used to assess postoperative pain directly after and 1, 8, 20 and 24 hours after awakening from general anesthesia. NRS scores of more than 2 and a PHHPS score of more than 1 were considered as pain requiring intervention. Hemodynamic stability and side effects were also compared between the groups.

RESULTS

The durations of the procedure and extubation times in groups R and B were similar (59 ±7 vs. 56 ±10 minutes and 9 ±5 vs. 10 ±5 minutes, respectively). Pain scores requiring intervention were below 10% and were recorded with similar frequency in both groups, except for one difference in the PHHPS score in favor of group R after 24 hours (12% vs. 40%, p < 0.05). The frequency of side effects and hemodynamic stability were similar in both groups.

CONCLUSIONS

0.1% epidural ropivacaine has no advantage over 0.0625% epidural bupivacaine for pectus excavatum repair in children.

Для цитирования: Walaszczyk Małgorzata, Wiench Rafał, Copik Maja, Karpe Jacek, Łowicka Małgorzata, Pióro Anna, Knapik Piotr, Misiołek Hanna. Ropivacaine has no advantage over bupivacaine in thoracic epidural analgesia for patients with pectus excavatum undergoing the Nuss procedure - a single blind randomized clinical trial comparing efficacy and safety.. Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery. 2018. DOI: 10.5114/kitp.2018.74668.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.